We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.

×

Aker BioMarine signs 18 strategic partnership agreements at China International Import Expo

Oslo, November 8, 2022: Aker BioMarine is onsite in Shanghai at China International Import Expo (CIIE) from November 5-10,...

Aker BioMarine strengthens QRILL™ Aqua sales team with new talent

(Oslo, September 6, 2022) Aker BioMarine is enhancing its QRILL™ Aqua sales organization after successfully recruiting two...

Aker BioMarine, CSIRO and Swisse winners of the 2022 Nutra Ingredients Asia Award

(Tuesday, September 6th, 2022) Aker BioMarine, CSIRO and Swisse took home this year’s Nutrition Research Project prize at...

First commercial agreement signed for Lysoveta

Oslo, 1 September 2022: Reference is made to the stock exchange release on 11 January 2021, with the announcement of the...

Aker BioMarine’s Patent Portfolio is Strengthened in the United States

(August 31, 2022) The United States Patent Trial and Appeal Board (PTAB) has rejected a challenge against Aker BioMarine’s...

Aker BioMarine - second quarter 2022

14 July 2022: Aker BioMarine ASA (“Aker BioMarine” or “the company”) reports revenues of USD 73 million and Adjusted EBITDA...

Aker BioMarine Supports Antarctic Ecosystem Research with USD 1 Million

(June 30th, 2022, Oslo) At the UN Ocean Conference in Lisbon this week, Aker BioMarine announced its commitment to support...

Aker BioMarine Supports Antarctic Ecosystem Research with USD 1 Million

(June 30th, 2022, Oslo) At the UN Ocean Conference in Lisbon this week, Aker BioMarine announced its commitment to support...

Aker BioMarine Supports Antarctic Ecosystem Research with USD 1 Million

(June 30th, 2022, Oslo) At the UN Ocean Conference in Lisbon this week, Aker BioMarine announced its commitment to support...